1268.6000 -40.90 (-3.12%)
NSE Oct 19, 2026 15:31 PM
Volume: 136.2K
 

1268.60
-3.12%
BOB Capital Markets Ltd.
Q3 revenue up 6% QoQ to Rs 5.4bn supported by sequential recovery in API business to parent and PLI benefits
Alivus Life Sciences has gained 37.40% in the last 1 Year
More from Alivus Life Sciences Ltd.
Recommended